OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)
Close on Nov 17, 2026Market cap $1.21BP/E –Yield –
OPKO Health price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
OPKO Health's price to book ratio was 1.1× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.5× to 1.6×, with a median of 0.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.1× | +0.4 |
| 2025 | Dec 31, 2025 | 0.7× | −0.1 |
| 2024 | Dec 31, 2024 | 0.8× | +0.0 |
| 2023 | Dec 29, 2023 | 0.8× | +0.3 |
| 2022 | Dec 30, 2022 | 0.5× | −1.0 |
| 2021 | Apr 30, 2021 | 1.6× | +0.8 |
| 2020 | Apr 30, 2020 | 0.8× | +0.1 |
| 2019 | Apr 30, 2019 | 0.8× | −0.2 |
| 2018 | Apr 30, 2018 | 0.9× | −1.2 |
| 2017 | Apr 28, 2017 | 2.1× | −0.5 |
| 2016 | Apr 29, 2016 | 2.6× | +0.3 |
| 2015 | Dec 31, 2015 | 2.4× | −2.3 |
| 2014 | Dec 31, 2014 | 4.7× | +1.5 |
| 2013 | Dec 31, 2013 | 3.2× | −5.6 |
| 2012 | Apr 30, 2012 | 8.8× | −5.2 |
| 2011 | Oct 31, 2011 | 13.9× | −13.1 |
| 2010 | Dec 31, 2010 | 27.1× | – |
See a number that looks wrong?